Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 1546 AL 1560

Hybrid Imaging of Vascular Cognitive Impairment

Frantellizzi V, Conte M, De Vincentis G.

Semin Nucl Med. 2021 May;51(3):286-295. doi: 10.1053/j.semnuclmed.2020.12.006. Epub 2020 Dec 20.

Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer's disease spectrum

Amaefule CO, Dyrba M, Wolfsgruber S, Polcher A, Schneider A, Fliessbach K, Spottke A, Meiberth D, Preis L, Peters O, Incesoy EI, Spruth EJ, Priller J, Altenstein S, Bartels C, Wiltfang J, Janowitz D, Bürger K, Laske C, Munk M, Rudolph J, Glanz W, Dobisch L, Haynes JD, Dechent P, Ertl-Wagner B, Scheffler K, Kilimann I, Düzel E, Metzger CD, Wagner M, Jessen F, Teipel SJ.

Neuroimage Clin. 2021;29:102533. doi: 10.1016/j.nicl.2020.102533. Epub 2020 Dec 17.

Alzheimer Disease Spectrum: Syndrome and Etiology From Clinical and PET Imaging Perspectives

Knopman DS, Jagust WJ.

Neurology. 2021 Feb 16;96(7):299-300. doi: 10.1212/WNL.0000000000011415. Epub 2020 Dec 22.

Zingiber officinale ameliorates Alzheimer's disease and Cognitive Impairments: Lessons from preclinical studies

Talebi M, İlgün S, Ebrahimi V, Talebi M, Farkhondeh T, Ebrahimi H, Samarghandian S.

Biomed Pharmacother. 2021 Jan;133:111088. doi: 10.1016/j.biopha.2020.111088. Epub 2020 Dec 15.

A meta-analysis on the levels of VILIP-1 in the CSF of Alzheimer's disease compared to normal controls and other neurodegenerative conditions

Mavroudis IA, Petridis F, Chatzikonstantinou S, Karantali E, Kazis D.

Aging Clin Exp Res. 2021 Feb;33(2):265-272. doi: 10.1007/s40520-019-01458-2. Epub 2020 Jan 14.

Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies

Zetterberg H, Bendlin BB.

Mol Psychiatry. 2021 Jan;26(1):296-308. doi: 10.1038/s41380-020-0721-9. Epub 2020 Apr 6.

The role of neurofilament light chain in frontotemporal dementia: a meta-analysis

Karantali E, Kazis D, Chatzikonstantinou S, Petridis F, Mavroudis I.

Aging Clin Exp Res. 2021 Apr;33(4):869-881. doi: 10.1007/s40520-020-01554-8. Epub 2020 Apr 18.

Diagnostic and therapeutic potential of exosomes in Alzheimer's disease

Soares Martins T, Trindade D, Vaz M, Campelo I, Almeida M, Trigo G, da Cruz E Silva OAB, Henriques AG.

J Neurochem. 2021 Jan;156(2):162-181. doi: 10.1111/jnc.15112. Epub 2020 Aug 6.

Narrative Review of Sensory Changes as a Biomarker for Alzheimer's Disease

Romano RR 3rd, Carter MA, Monroe TB.

Biol Res Nurs. 2021 Apr;23(2):223-230. doi: 10.1177/1099800420947176. Epub 2020 Aug 17.

Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use

Gavrilova SI, Alvarez A.

Med Res Rev. 2021 Sep;41(5):2775-2803. doi: 10.1002/med.21722. Epub 2020 Aug 17.

Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances

Gupta VB, Chitranshi N, den Haan J, Mirzaei M, You Y, Lim JK, Basavarajappa D, Godinez A, Di Angelantonio S, Sachdev P, Salekdeh GH, Bouwman F, Graham S, Gupta V.

Prog Retin Eye Res. 2021 May;82:100899. doi: 10.1016/j.preteyeres.2020.100899. Epub 2020 Sep 2.

Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau

Rayaprolu S, Higginbotham L, Bagchi P, Watson CM, Zhang T, Levey AI, Rangaraju S, Seyfried NT.

Neuropsychopharmacology. 2021 Jan;46(1):98-115. doi: 10.1038/s41386-020-00840-3. Epub 2020 Sep 8.

Alzheimer's disease and type 2 diabetes mellitus: A systematic review of proteomic studies

Diniz Pereira J, Gomes Fraga V, Morais Santos AL, Carvalho MDG, Caramelli P, Braga Gomes K.

J Neurochem. 2021 Mar;156(6):753-776. doi: 10.1111/jnc.15166. Epub 2020 Oct 7.

Plasma isoprostanoids assessment as Alzheimer's disease progression biomarkers

Peña-Bautista C, Álvarez L, Baquero M, Ferrer I, García L, Hervás-Marín D, Cháfer-Pericás C.

J Neurochem. 2021 Jun;157(6):2187-2194. doi: 10.1111/jnc.15183. Epub 2020 Sep 30.

Sleep-disordered breathing and the risk of Alzheimer's disease

Liguori C, Maestri M, Spanetta M, Placidi F, Bonanni E, Mercuri NB, Guarnieri B.

Sleep Med Rev. 2021 Feb;55:101375. doi: 10.1016/j.smrv.2020.101375. Epub 2020 Sep 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias